Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NSCLC × Cryotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Warts 12 Keratosis, Actinic 12 Breast Neoplasms 11 Prostatic Neoplasms 10 Uterine Cervical Dysplasia 7 Retinoblastoma 7 Peripheral Nervous System Diseases 6 Pain 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Neoplasms 5 Stomatitis 4 Esophageal Neoplasms 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Mucositis 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Papillomavirus Infections 2 Multiple Myeloma 2 Mesothelioma 2 Melanoma 2 Keratosis 2 Deglutition Disorders 2 Condylomata Acuminata 2 Carcinoma, Ductal, Breast 2 Carcinoma, Basal Cell 2 Bone Neoplasms 2 Barrett Esophagus 2

Interventions

Pemetrexed 14 Carboplatin 12 osimertinib 11 Drug Therapy 9 aflutinib 8 Gefitinib 8 Radiotherapy 6 Docetaxel 6 Cisplatin 6 pembrolizumab 5 anlotinib 5 Radiosurgery 5 icotinib 4 Vinorelbine 4 Paclitaxel 4 Gemcitabine 4 Erlotinib Hydrochloride 4 tislelizumab 3 camrelizumab 3 apatinib 3 HM781-36B 3 toripalimab 2 spartalizumab 2 rezivertinib 2 dacomitinib 2 Tyrosine Kinase Inhibitors 2 Thalidomide 2 Surgical Procedures, Operative 2 S 1 (combination) 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07530744 2026-04-15

Cronos

Elisabethinen Hospital

Phase NA Not yet recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡